| REVIEW ARTICLE |
|
| Year : 2018 | Volume
: 11
| Issue : 2 | Page : 103-112 |
|
|
Central serous chorioretinopathy: Current update on pathophysiology and multimodal imaging
George Joseph Manayath, Ratnesh Ranjan, Vanee Sheth Shah, Smita S Karandikar, Veerappan R Saravanan, Venkatapathy Narendran
Department of Vitreo-Retina Services, Aravind Eye Hospital and Post-graduate Institute of Ophthalmology, Coimbatore, Tamilnadu, India
Correspondence Address:
Ratnesh Ranjan
Aravind Eye Hospital and Post-graduate Institute of Ophthalmology, Coimbatore - 641 014, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ojo.OJO_75_2017
|
|
|
Central serous chorioretinopathy (CSC), the fourth most common nonsurgical retinopathy, is characterized by serous retinal detachment most commonly involving the macular region. Although natural history of CSC shows a self-limiting course, patients are known to present with persistent, recurrent, or even bilateral CSC with distressing visual loss. Multimodal imaging techniques for CSC include optical coherence tomography (OCT) with enhanced depth imaging, fundus autofluorescence, fluorescein angiography, indocyanine green angiography, and OCT angiography. Evolution of new imaging techniques in addition to conventional imaging modalities has revolutionized the understanding about the pathophysiology of CSC and hence the diagnosis and management. This review article elaborates on current understanding about pathophysiology and risk factors, as well as multimodal imaging-based features of CSC.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
